U24ES036819
Cooperative Agreement
Overview
Grant Description
NEXUS: Network for Exposomics in the U.S. - Project Summary
The Network for Exposomics in the U.S. or NEXUS is designed to advance the science of exposomics.
Our team is focused on operationalizing the exposome by advancing measurement and modeling technologies and applying them to human health outcomes.
We propose to coordinate current and future NIH-funded efforts on exposomics, and will strive to transform the entire biomedical and public health enterprise by inculcating the importance of comprehensive and systematic analysis of the environmental drivers of health and disease.
We are confident that through our highly interconnected and globally distributed NEXUS team, we can drive this innovation and recalibrate the historically imbalanced gene x environment equation.
We hypothesize that the NEXUS team can operationalize and embed exposomics throughout the entire biomedical enterprise to advance precision environmental health, which will be achieved through the following specific aims:
Aim 1. To provide outstanding organizational support and enable stakeholder engagement through the establishment of the administrative and stakeholder engagement hub.
Aim 2. To establish a framework for exposomics analysis of biological and environmental samples through the formation of the Chembio Analytical Sciences Hub.
Aim 3: To develop a framework for geospatial-based exposomics studies of environmental and social influences on health and disease including a scalable geospatial data science and research infrastructure via the formation of the Geospatial Sciences Hub.
Aim 4: To create a comprehensive exposomics digital framework to support precision environmental health via the formation of the NEXUS Data Sciences Hub.
We will support a dynamic community of practice, develop the constellation and beliefs inherent in a given scientific discipline, and advance our understanding of the environmental drivers of health and disease.
Moreover, this project will establish the standard for exposomics profiling that integrates digital, biological, and geospatial markers to make exposome-wide association studies (EXWAS) a reality for studies of all human diseases establishing the paradigm for how we study the environment and human disease and providing the environmental complement to genomics that was envisioned in 2005.
The Network for Exposomics in the U.S. or NEXUS is designed to advance the science of exposomics.
Our team is focused on operationalizing the exposome by advancing measurement and modeling technologies and applying them to human health outcomes.
We propose to coordinate current and future NIH-funded efforts on exposomics, and will strive to transform the entire biomedical and public health enterprise by inculcating the importance of comprehensive and systematic analysis of the environmental drivers of health and disease.
We are confident that through our highly interconnected and globally distributed NEXUS team, we can drive this innovation and recalibrate the historically imbalanced gene x environment equation.
We hypothesize that the NEXUS team can operationalize and embed exposomics throughout the entire biomedical enterprise to advance precision environmental health, which will be achieved through the following specific aims:
Aim 1. To provide outstanding organizational support and enable stakeholder engagement through the establishment of the administrative and stakeholder engagement hub.
Aim 2. To establish a framework for exposomics analysis of biological and environmental samples through the formation of the Chembio Analytical Sciences Hub.
Aim 3: To develop a framework for geospatial-based exposomics studies of environmental and social influences on health and disease including a scalable geospatial data science and research infrastructure via the formation of the Geospatial Sciences Hub.
Aim 4: To create a comprehensive exposomics digital framework to support precision environmental health via the formation of the NEXUS Data Sciences Hub.
We will support a dynamic community of practice, develop the constellation and beliefs inherent in a given scientific discipline, and advance our understanding of the environmental drivers of health and disease.
Moreover, this project will establish the standard for exposomics profiling that integrates digital, biological, and geospatial markers to make exposome-wide association studies (EXWAS) a reality for studies of all human diseases establishing the paradigm for how we study the environment and human disease and providing the environmental complement to genomics that was envisioned in 2005.
Funding Goals
TO FOSTER UNDERSTANDING OF HUMAN HEALTH EFFECTS OF EXPOSURE TO ENVIRONMENTAL AGENTS IN THE HOPE THAT THESE STUDIES WILL LEAD TO: THE IDENTIFICATION OF AGENTS THAT POSE A HAZARD AND THREAT OF DISEASE, DISORDERS AND DEFECTS IN HUMANS, THE DEVELOPMENT OF EFFECTIVE PUBLIC HEALTH OR DISEASE PREVENTION STRATEGIES, THE OVERALL IMPROVEMENT OF HUMAN HEALTH EFFECTS DUE TO ENVIRONMENTAL AGENTS, THE DEVELOPMENT OF PRODUCTS AND TECHNOLOGIES DESIGNED TO BETTER STUDY OR AMELIORATE THE EFFECTS OF ENVIRONMENTAL AGENTS, AND THE SUCCESSFUL TRAINING OF RESEARCH SCIENTISTS IN ALL AREAS OF ENVIRONMENTAL HEALTH RESEARCH. SUPPORTED GRANT PROGRAMS FOCUS ON THE FOLLOWING AREAS: (1) UNDERSTANDING BIOLOGICAL RESPONSES TO ENVIRONMENTAL AGENTS BY DETERMINING HOW CHEMICAL AND PHYSICAL AGENTS CAUSE PATHOLOGICAL CHANGES IN MOLECULES, CELLS, TISSUES, AND ORGANS, AND BECOME MANIFESTED AS RESPIRATORY DISEASE, NEUROLOGICAL, BEHAVIORAL AND DEVELOPMENTAL ABNORMALITIES, CANCER, AND OTHER DISORDERS, (2) DETERMINING THE MECHANISMS OF TOXICITY OF UBIQUITOUS AGENTS LIKE METALS, NATURAL AND SYNTHETIC CHEMICALS, PESTICIDES, AND MATERIALS SUCH AS NANOPARTICLES, AND NATURAL TOXIC SUBSTANCES, AND THEIR EFFECTS OF ON VARIOUS HUMAN ORGAN SYSTEMS, ON METABOLISM, ON THE ENDOCRINE AND IMMUNE SYSTEMS, AND ON OTHER BIOLOGICAL FUNCTIONS, (3) DEVELOPING AND INTEGRATING SCIENTIFIC KNOWLEDGE ABOUT POTENTIALLY TOXIC AND HAZARDOUS CHEMICALS BY CONCENTRATING ON TOXICOLOGICAL RESEARCH, TESTING, TEST DEVELOPMENT, VALIDATION AND RISK ESTIMATION, (4) IDENTIFYING INTERACTIONS BETWEEN ENVIRONMENTAL STRESSORS AND GENETIC SUSCEPTIBILITY AND UNDERSTANDING BIOLOGIC MECHANISMS UNDERLYING THESE INTERACTIONS, INCLUDING THE STUDY OF ENVIRONMENTAL INFLUENCES ON EPIGENOMICS AND TRANSCRIPTIONAL REGULATION, (5) CONDUCTING ENVIRONMENTAL PUBLIC HEALTH RESEARCH, INCLUDING IN AREAS OF ENVIRONMENTAL JUSTICE AND HEALTH DISPARITIES, THAT REQUIRES COMMUNITIES AS ACTIVE PARTICIPANTS IN ALL STAGES OF RESEARCH, DISSEMINATION, AND EVALUATION TO ADVANCE BOTH THE SCIENCE AND THE DEVELOPMENT OF PRACTICAL MATERIALS FOR USE IN COMMUNITIES, WITH A FOCUS ON TRANSLATING RESEARCH FINDINGS INTO TOOLS, MATERIALS, AND RESOURCES THAT CAN BE USED TO PREVENT, REDUCE, OR ELIMINATE ADVERSE HEALTH OUTCOMES CAUSED BY ENVIRONMENTAL EXPOSURES, (6) EXPANDING AND IMPROVING THE SBIR PROGRAM, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION, (7) EXPANDING AND IMPROVING THE STTR PROGRAM TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH AND DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION, (8) PROVIDING SUPPORT FOR BROADLY BASED MULTI-DISCIPLINARY RESEARCH AND TRAINING PROGRAMS IN ENVIRONMENTAL HEALTH .THESE PROGRAMS INCLUDE THE ENVIRONMENTAL HEALTH SCIENCES CORE CENTERS , WHICH SERVE AS NATIONAL FOCAL POINTS AND RESOURCES FOR RESEARCH AND MANPOWER DEVELOPMENT. THROUGH THESE PROGRAMS, NIEHS EXPECTS TO ACHIEVE THE LONG-RANGE GOAL OF DEVELOPING NEW CLINICAL AND PUBLIC HEALTH APPLICATIONS TO IMPROVE DISEASE PREVENTION, DIAGNOSIS, AND THERAPY. ADDITIONAL CENTERS PROGRAMS DEVELOPED IN RECENT YEARS, INCLUDE THE CENTERS FOR OCEANS AND HUMAN HEALTH (CO-FUNDED WITH NSF), CHILDREN'S ENVIRONMENTAL HEALTH CENTERS (CO-FUNDED WITH US EPA) AND THE AUTISM CENTERS OF EXCELLENCE (CO-FUNDED WITH OTHER NIH INSTITUTES), AND THE HUMAN HEALTH EXPOSURE ANALYSIS RESOURCE (HHEAR) PROGRAM, (9) SUPPORTING RESEARCH TRAINING PROGRAMS WHICH SERVE TO INCREASE THE POOL OF TRAINED RESEARCH MANPOWER WITH NEEDED EXPERTISE IN THE ENVIRONMENTAL HEALTH SCIENCES THROUGH SUPPORT OF INDIVIDUAL AND INSTITUTIONAL NATIONAL RESEARCH SERVICE AWARDS (NRSAS), (10) THE OUTSTANDING NEW ENVIRONMENTAL SCIENTIST PROGRAM WHICH PROVIDES FIRST TIME RESEARCH GRANT FUNDING TO OUTSTANDING JUNIOR SCIENTISTS IN THE FORMATIVE STAGES OF THEIR CAREER WHO ARE PROPOSING TO MAKE A LONG TERM COMMITMENT TO ENVIRONMENTAL HEALTH SCIENCES RESEARCH AND TO ADDRESS THE ADVERSE EFFECTS ON ENVIRONMENTAL EXPOSURES ON HUMAN BIOLOGY, HUMAN PATHOPHYSIOLOGY AND HUMAN DISEASE.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
100323727
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 6089% from $50,000 to $3,094,527.
The Trustees Of Columbia University In The City Of New York was awarded
NEXUS Exposomics Project: Advancing Precision Environmental Health
Cooperative Agreement U24ES036819
worth $3,094,527
from the National Institute of Environmental Health Sciences in September 2024 with work to be completed primarily in New York New York United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.113 Environmental Health.
The Cooperative Agreement was awarded through grant opportunity Center for Exposome Research Coordination to Accelerate Precision Environmental Health (U24 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 8/20/25
Period of Performance
9/4/24
Start Date
8/31/29
End Date
Funding Split
$3.1M
Federal Obligation
$0.0
Non-Federal Obligation
$3.1M
Total Obligated
Activity Timeline
Transaction History
Modifications to U24ES036819
Additional Detail
Award ID FAIN
U24ES036819
SAI Number
U24ES036819-699151038
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NV00 NIH National Institute of Enviromental Health Sciences
Funding Office
75NV00 NIH National Institute of Enviromental Health Sciences
Awardee UEI
QHF5ZZ114M72
Awardee CAGE
3FHD3
Performance District
NY-13
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Modified: 8/20/25